Baird lowered the firm’s price target on Henry Schein to $82 from $92 and keeps an Outperform rating on the shares. The firm admitted Q2 wasn’t great but said for a name where gross margins has structurally improved and 2025 growth should improve even in the absence of notable end-market improvements, they consider that too low and still see a path higher for shares over the next 12 months.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.